Differentiation between High- and Low-Grade Astrocytoma Using a Human Recombinant Antibody to the Extra Domain-B of Fibronectin
- 1 November 2002
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 161 (5) , 1695-1700
- https://doi.org/10.1016/s0002-9440(10)64446-x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED‐B domain of fibronectinInternational Journal of Cancer, 2002
- Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculatureNature Biotechnology, 2002
- Identification of a Glioblastoma-Associated Tenascin-C Isoform by a High Affinity Recombinant AntibodyThe American Journal of Pathology, 1999
- Observer reliability in histological grading of astrocytoma stereotactic biopsiesJournal of Neurosurgery, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- The Alternative Splicing Pattern of the Tenascin-C Pre-mRNA Is Controlled by the Extracellular pHJournal of Biological Chemistry, 1995
- The fibronectin isoform containing the ed‐b oncofetal domain: A marker of angiogenesisInternational Journal of Cancer, 1994
- Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissuesInternational Journal of Cancer, 1994
- Transforming growth factor‐β regulates the splicing pattern of fibronectin messenger RNA precursorFEBS Letters, 1990
- A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors.The Journal of cell biology, 1989